Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017)

Crinetics Pharmaceuticals (CRNX) has 1 years of Times Interest Earned data on record, last reported at -$2501.0 in Q4 2017.

  • For Q4 2017, Times Interest Earned changed N/A year-over-year to -$2501.0; the TTM value through Sep 2018 reached -$21780.0, changed N/A, while the annual FY2017 figure was -$1140.9, 107.64% down from the prior year.
  • Times Interest Earned reached -$2501.0 in Q4 2017 per CRNX's latest filing, down from -$1187.0 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$1187.0 in Q3 2017 and bottomed at -$2501.0 in Q4 2017.